Alantra advises Farmaè Group on the acquisition of AmicaFarmacia

Jun 2021

Buy-side advisory

Milan, 29 June 2021 – Alantra, the global investment banking and asset management specialist, has advised Farmaè Group (“Farmaè”), the leading Italian online retailer of beauty & personal care and OTC products, on the acquisition of AmicaFarmacia S.r.l. (“AmicaFarmacia), the second-largest player in the industry.

With an aggregate revenue of more than €93 million in 2020, the transaction positions Farmaè as the first group in Italy with a leadership in the omnichannel distribution of over-the-counter medicines and health products. Following Farmaè Group’s listing on the stock exchange in 2019, this transaction marks a milestone in the future of the company, with the aim to serve an increasing pool of customers, which today reaches almost 60 million customer bases, and with the ability to offer brands and companies innovative platforms that, thanks to the potential of digital, artificial intelligence and new technologies, can explore unique sales opportunities.

The transaction will also allow growth of revenues from online platforms, the launch of synergies aimed at improving the economies of scale of the business, the expansion of logistics capacity, new commercial opportunities with industrial partners and the release of new technologies.

Stefano Bellavita, Managing Partner at Alantra, commented on the deal: “After acting as NOMAD and global coordinator in Farmaè’s IPO in 2019, we are thrilled to help the company consolidate its market leadership and accelerate the development of the business model in Italy”.